INVESTIGATION OF THE EFFECT OF EFFLUX PUMP INHIBITORS TO MIC VALUES OF CIPROFLOXACIN IN CLINICAL ISOLATES OF PSEUDOMONAS AERUGINOSA, ESCHERICHIA COLI, ACINETOBACTER BAUMANNII AND STAPHYLOCOCCUS AUREUS

Cetinkaya E., Coban A. Y., Durupinar B.

MIKROBIYOLOJI BULTENI, cilt.42, sa.4, ss.553-561, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 4
  • Basım Tarihi: 2008
  • Dergi Adı: MIKROBIYOLOJI BULTENI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.553-561
  • Anahtar Kelimeler: Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, ciprofloxacin, resistance, efflux pump, phenylalanyl-arginyl-beta-naphtylamide, reserpine, MULTIDRUG-RESISTANCE, 1-(1-NAPHTHYLMETHYL)-PIPERAZINE, SYSTEMS, NORA
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

The aim of this study was to investigate the effects of efflux pump inhibitors on the minimal inhibitory concentration (MIC) values of ciprofloxacin (CIP) in fluoroquinolone-resistant 42 Pseudomonas aeruginosa (n= 42), Escherichia coli (n= 97), Acinetobacter baumannii (n= 58) and Staphylococcus aureus (n= 80) strains isolated from clinical specimens. Par this purpose phenylalanyl-arginyl-beta-naphthylamide (PA beta N) was used for P.aeruginosa, E.coli, A.baumannii and reserpine for S.aureus isolates as pump inhibitors. Fluoroquinolone resistance of the clinical isolates were determined by VITEK2 Compact (BioMerieux, France) automated system and confirmed with standard broth microdilution method. For the investigation of the effects of inhibitor agents, the MIC values were also determined in the presence of 25 mu g/ml and 100 mu g/ml PA beta N and 20 mu g/ml reserpine. In the presence of 25 mg/l PA beta N, 61.9% of CIP resistant P.aeruginosa strains converted to susceptible ones, while this rate was 73.8% in the presence of 100 mg/l PARN. In A.baumannii clinical isolates, 8.6% and 15.5% of CIP-resistant strains have become susceptible in the presence of 25 mg/l and 100 mg/l PARN, respectively. Similarly the MIC values for CIP have decreased >= 4 folds in 42.2%, and >= 2 folds in 30.9% of E.coli isolates, in the presence of 25 mg/l PARN, however, there was no change in MICs of 26.9% of E.coli strains. The MIC values have also been lowered for >= 4 folds in 83.6%, and two folds in 13.4% of E.coli strains by the use of 100 mg/l PARN concentration, however, no decrease in MIC values was detected in 3% of the isolates. 20 mg/l of reserpine have caused a decrease of >= 4 folds in 8.75%, and two folds in 33.75% of S.aureus isolates, while there was no change in MIC values of 57.5% of S.aureus strains. Our results showed that PARN causes significant reduction in MIC values for CIP in the clinical isolates of P.aeruginosa, E.coli and A.baumannii and this effect may be attributed to efflux pump inhibition. In contrast, it was concluded that reserpine does not have a considerable effect on the MIC values of S.aureus against ciprofloxacin.